St Mary's Hospital is a hospital located on the outskirts of Newport on the Isle of Wight. It is run by the Isle of Wight NHS Trust.

There are 296 beds in St. Mary's Hospital.

During the past decade, St. Mary's Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Mary's Hospital" #1 sponsor was "Boehringer Ingelheim" with 2 trials, followed by "Pfizer" with 2 trials sponsored, "University of Southampton" with 2 trials sponsored, "Cancer Research UK" with 1 trials sponsored and "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Mary's Hospital" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "National Institute for Health Research, United Kingdom" with 2 trials as a collaborator, "University Hospital Southampton NHS Foundation Trust" with 2 trials as a collaborator, "Alder Hey Children's NHS Foundation Trust" with 1 trials as a collaborator and "Basingstoke and North Hampshire Hospital" with 1 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "St. Mary's Hospital" are "Colorectal Cancer" (3 trials), "Breast Cancer" (2 trials), "Cardiovascular Disease" (2 trials), "Heart Failure" (2 trials) and "Metastatic Cancer" (2 trials). Many other conditions were trialed in "St. Mary's Hospital" in a lesser frequency.

Most popular intervention types in "St. Mary's Hospital" are "Drug" (13 trials), "Procedure" (6 trials), "Biological" (3 trials), "Other" (3 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "capecitabine" (5 trials), "Placebo" (4 trials), "adjuvant therapy" (4 trials), "fluorouracil" (3 trials) and "oxaliplatin" (3 trials). Other intervention names were less common.

The vast majority of trials in "St. Mary's Hospital" are 14 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "St. Mary's Hospital". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in St. Mary's Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in St. Mary's Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".